Harpagoside
Harpagoside is a bioactive small molecule with demonstrated anti-inflammatory properties, including the inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in LPS-stimulated HepG2 cells. It is utilized in inflammation research and has shown moderate inhibitory effects on seed germination at millimolar concentrations.
Product Specifications
CAS Number
19210-12-9
Product Name Alternative
Nitric oxide synthases, NO Synthase, inhibit, NOS, NOSynthase, Harpagoside, Inhibitor, COX, Cyclooxygenase
Field of Research
Immunology & Inflammation, Neuroscience
Purity
≥95% (May vary between batches)
Solubility
Ethanol:Soluble; DMSO:90 mg/mL (182.01 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (10.11 mM) ; Pyridine, Methanol, etc.:Soluble
Smiles
C[C@@]1 (C[C@@H] (O) [C@]2 (O) C=CO[C@@H] (O[C@@H]3O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@H]3O) [C@H]12) OC (=O) \C=C\c1ccccc1
Molecular Formula
C24H30O11
Molecular Weight
494.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human AMPD2 sgRNA gene knockout kit - Lentiviral human AMPD2 sgRNA gene knockout kit (plasmid)